Detalles de la búsqueda
1.
Patient preferences for chronic lymphocytic leukemia treatments: a discrete-choice experiment.
Future Oncol
; : 1-12, 2024 May 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38861284
2.
Quality of Pharmacist-Managed Anticoagulation Therapy in Long-Term Ambulatory Settings: A Systematic Review.
Ann Pharmacother
; 51(12): 1122-1137, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28735551
3.
High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy.
J Thromb Thrombolysis
; 44(4): 435-441, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-29027097
4.
Comparative effectiveness of patient-centered strategies to improve FDA medication guides.
Med Care
; 52(9): 781-9, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25119953
5.
Real-World Health Care Resource Use and Costs Among Patients With Chronic Lymphocytic Leukemia Treated With Venetoclax-Based and Bruton Tyrosine Kinase Inhibitor-Based Regimens in the Second-Line Setting.
JCO Oncol Pract
; : OP2300630, 2024 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38626366
6.
A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada.
Pharmacoecon Open
; 7(2): 199-216, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36334238
7.
Real-world adherence and discontinuation among Medicare beneficiaries initiating venetoclax vs. BTKis in relapsed/refractory chronic lymphocytic leukemia.
Leuk Lymphoma
; 64(14): 2316-2323, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37732602
8.
Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.
Clin Lymphoma Myeloma Leuk
; 23(7): 515-526, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37076367
9.
Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States.
J Manag Care Spec Pharm
; 27(11): 1532-1544, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714110
10.
Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States.
Pharmacoeconomics
; 38(9): 941-951, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32383129
11.
Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner-City Population.
Pharmacotherapy
; 38(2): 205-216, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29286540
12.
Updated quality of life data from the phase 3b VENICE II trial: patients with relapsed or refractory chronic lymphocytic leukemia receiving venetoclax monotherapy.
Leuk Lymphoma
; : 1-4, 2023 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37626019
13.
Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.
Pharmacotherapy
; 37(10): 1221-1230, 2017 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-28730619
14.
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen.
Blood Adv
; 6(15): 4553-4557, 2022 08 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35736670
15.
Drug-Alcohol Interactions in Older U.S. Adults.
J Am Geriatr Soc
; 63(11): 2324-31, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26503899
Resultados
1 -
15
de 15
1
Próxima >
>>